Dragana Milosevic

ORCID: 0000-0003-3479-2512
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Adrenal and Paraganglionic Tumors
  • Hormonal Regulation and Hypertension
  • Cancer, Hypoxia, and Metabolism
  • Cancer Genomics and Diagnostics
  • Glioma Diagnosis and Treatment
  • Thyroid Cancer Diagnosis and Treatment
  • Pancreatic and Hepatic Oncology Research
  • Cancer-related Molecular Pathways
  • Epigenetics and DNA Methylation
  • RNA modifications and cancer
  • Renal cell carcinoma treatment
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Cardiovascular Disease and Adiposity
  • Mesenchymal stem cell research
  • Renal and related cancers
  • Vascular Malformations and Hemangiomas
  • Virus-based gene therapy research
  • Pituitary Gland Disorders and Treatments
  • Viral Infectious Diseases and Gene Expression in Insects
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • MicroRNA in disease regulation
  • Cancer Immunotherapy and Biomarkers
  • Adipokines, Inflammation, and Metabolic Diseases
  • Brain Metastases and Treatment
  • Inflammatory Biomarkers in Disease Prognosis

Mayo Clinic
2010-2025

Mayo Clinic in Arizona
2011-2023

WinnMed
2011-2021

University of Padua
2020

University of Ottawa
2020

Duke University
2020

Dell Children's Medical Center of Central Texas
2019

University of Novi Sad
2018

National Institutes of Health
2011-2016

Memorial Sloan Kettering Cancer Center
2016

The immunosuppressive properties of morbilliviruses including measles and canine distemper virus (CDV) are well known, but the host cells supporting infection poorly characterized. To identify these cells, a recombinant CDV expressing green fluorescent protein was produced by reverse genetics based on wild-type strain lethal for ferrets. This fully retained virulence blazed three lymphocyte-based pathways through immune system its host: first, it infected rapidly massively circulating B T...

10.1073/pnas.0403597101 article EN Proceedings of the National Academy of Sciences 2004-09-17

Purpose To present data on the high rate of SDHB mutations in patients with metastatic pheochromocytoma/paraganglioma whose initial tumor presentation began childhood or adolescence. Patients and Methods From 2000 to 2010, 263 were evaluated through National Institutes Health (NIH), Bethesda, MD. Of patients, 125 found have disease; these 32 presented a before 20 years age. An additional 17 age but demonstrated no development disease. Genetic testing for VHL, MEN, SDHB/C/D genes was...

10.1200/jco.2011.34.6353 article EN Journal of Clinical Oncology 2011-10-04

Abstract Pleomorphic xanthoastrocytoma (PXA) is a rare astrocytoma predominantly affecting children and young adults. We performed comprehensive genomic characterization on cohort of 67 patients with histologically defined PXA (n = 53, 79%) or anaplastic (A‐PXA, n 14, 21%), including copy number analysis (ThermoFisher Oncoscan, 67), methylation profiling (Illumina EPIC array, 43) targeted next generation sequencing 32). The most frequent alterations were CDKN2A/B deletion 63; 94%) BRAF...

10.1111/bpa.12874 article EN Brain Pathology 2020-07-03

Anaplastic thyroid carcinoma (ATC) is a highly aggressive in need of therapeutic options. One critical component drug discovery the availability well-characterized cell lines for identification molecular mechanisms related to tumor biology and responsiveness. Up 42% human cancer are redundant or not correct tissue origin, comprehensive analysis currently nonexistent. Mechanistically, RhoB has been identified as novel target ATC therapy.The aim was develop four detailing genetic, molecular,...

10.1210/jc.2010-1421 article EN The Journal of Clinical Endocrinology & Metabolism 2010-09-01

Diabetes mellitus (DM) with its micro- and macrocomplications is the leading global epidemic of 21st century. The aim research to determine possible changes in complete blood count (CBC) parameters depending on glycemic controlin patients Type 2 diabetes (T2DM).

10.2478/jomb-2018-0021 article EN cc-by Journal of Medical Biochemistry 2018-09-12

Context: The BRAFT1799A transversion is the most frequent morphotype-specific somatic mutation in papillary thyroid carcinoma (PTC). ability to detect this circulation could aid diagnosis and follow-up of PTC patients.

10.1210/jc.2009-1349 article EN The Journal of Clinical Endocrinology & Metabolism 2009-12-01

Eur J Clin Invest 2011; 41 (10): 1121–1128 Abstract Background Pheochromocytomas are tumours arising from chromaffin tissue located in the adrenal medulla associated with typical symptoms and signs which may occasionally develop metastases, defined as presence of tumour cells at sites where these not found. This retrospective analysis was focused on clinical, genetic histopathologic characteristics primary metastatic versus benign pheochromocytomas. Materials methods We identified subjects...

10.1111/j.1365-2362.2011.02518.x article EN European Journal of Clinical Investigation 2011-04-01

Organ of Zuckerkandl paragangliomas (PGLs) are rare neuroendocrine tumors that derived from chromaffin cells located around the origin inferior mesenteric artery extending to level aortic bifurcation. Mutations in genes encoding succinate dehydrogenase subunits (SDH) B, C, and D (SDHx) have been associated with PGLs, but their contribution PGLs organ is not known. We aimed describe clinical presentation patients investigate prevalence SDHx mutations other genetic defects among them. The...

10.1677/erc-10-0004 article EN Endocrine Related Cancer 2010-04-24

In vitro studies have demonstrated that the PAX8/PPARγ fusion protein (PPFP), which occurs frequently in follicular thyroid carcinomas (FTC), exhibits oncogenic activity. However, paradoxically, a meta-analysis of extant tumor outcome indicates 68% FTC-expressing PPFP are minimally invasive compared to only 32% those lacking (χ2 = 6.86, P 0.008), suggesting favorably impacts FTC outcomes. designed distinguish benign neoplasms from carcinomas, previously identified suppressor miR-122, major...

10.1177/1947601911405045 article EN Genes & Cancer 2011-01-01

Abstract MAPK pathway activation has been recurrently observed in desmoplastic infantile ganglioglioma/astrocytoma (DIG/DIA) with reported disproportionally low mutation allele frequencies relative to the apparent high tumor content, suggesting that alterations may be subclonal. We sought expand number of molecularly profiled cases and investigate if cell composition could account for frequencies. Molecular (targeted neuro-oncology next-generation sequencing/RNA sequencing OncoScan...

10.1093/jnen/nlz086 article EN Journal of Neuropathology & Experimental Neurology 2019-09-28

Background and Aims: Early identification of malignant biliary strictures (MBSs) is challenging, with up to 20% classified as indeterminants after preliminary testing tissue sampling endoscopic retrograde cholangiopancreatography. We aimed evaluate the use methylated DNA markers (MDMs) from brushings enhance MBS detection in a prospective cohort. Approach: Candidate MDMs were evaluated for their utility diagnosis through series discovery validation phases. was extracted brushing samples,...

10.1097/hep.0000000000000970 article EN Hepatology 2024-06-21

To investigate the molecular underpinnings of thyroid cancer, preclinical cell line models are crucial; however, ∼40% these have been proven to be either duplicates existing lines or even nonthyroid-derived not derived from humans at all. Therefore, we set out establish procedures and guidelines that should proactively avoid problems, which facilitated creation criteria make valid for cancer research.Based on our recommendations, systematically characterized all new generated by a...

10.1210/jc.2017-01845 article EN The Journal of Clinical Endocrinology & Metabolism 2018-05-25

Vascular endothelial growth factor-targeted kinase inhibitors have emerged as highly promising therapies for radioiodine-refractory metastatic differentiated thyroid cancer. Unfortunately, drug resistance uniformly develops, limiting their therapeutic efficacies and thereby constituting a major clinical problem.To study acquired elucidate underlying mechanisms in this setting, BHP2-7 human cancer cells were subjected to prolonged continuous vitro selection with 18 μM pazopanib, clinically...

10.1210/jc.2013-2658 article EN The Journal of Clinical Endocrinology & Metabolism 2014-03-14

Insulin-like growth factor-1 (IGF-1) measurement by high-resolution accurate mass-mass spectrometry (HRAM-MS) is replacing IGF-1 immunoassays and allows for identification of single amino acid variants; contrast, both normal deleterious sequence variants might be missed or non-HRAM-MS methods. We have developed an intact molecule HRAM-MS method to identify variants, distinguishing them a center mass (COM) calculation, followed various tandem-MS activation techniques (HCD, ETD, ETciD, EThcD,...

10.1021/acs.jproteome.9b00494 article EN Journal of Proteome Research 2019-11-18
Coming Soon ...